Mkts

Lifecore Biomedical, Inc.

NASDAQ: LFCR
$6.40+0.01 (+0.16%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
6.396.41
52-week range
3.638.98
Today
Open6.40
Previous close6.40
Volume970.2K
Valuation
Market cap242.22M
P/E ratio—
EPS (TTM)-2.10
Income & risk
Dividend / yield—
Beta0.89
Avg volume330.5K
Discussion

LFCR News

Stories mentioning LFCR from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q3 '25Sep 30Q2 '25May 25Q1 '25Feb 23Q4 '24Nov 24Q3 '24Aug 25Q2 '24May 26Q1 '24Feb 25
Income Statement
Revenue
Cost of Goods Sold18,73123,31822,46225,30921,48019,31820,61423,810
Gross Profit4,4627,79113,9829,84511,0845,38717,27111,894
Operating Expenses
Research & Development1,2171,9632,1032,0451,9242,1862,1612,170
Sales General & Admin7,9178,8958,1649,97811,11914,78512,0779,848
Total Operating Expenses13,04316,97115,12312,789
Operating Income (Loss)(4,672)(3,067)5,327(9,029)(1,959)(11,584)2,148(895.00)
Interest Income128.0058.00108.0015.00
Interest Expense
Other Expense110.00110.00171.00333.00(304.00)(203.00)(1,101)(814.00)
Pretax Income(14,937)(9,658)(1,114)(14,777)(6,528)(16,255)(7,143)15,002
Tax Provision43.00333.0033.00(8.00)43.00(25.00)(57.00)217.00
Net Income (Loss)(14,980)(9,991)(1,147)(14,769)(6,571)(16,230)(7,083)15,632
Earnings Per Share (Basic)(0.43)(0.29)(0.03)(0.42)(0.25)(0.53)(0.23)0.51
Earnings Per Share (Diluted)(0.43)(0.29)(0.03)(0.42)(0.25)(0.53)(0.19)0.42
Weighted Average Shares Outstanding (Basic)37,47737,40334,81937,02134,36130,85630,47430,488
Weighted Average Shares Outstanding (Diluted)37,47737,40334,81937,02134,36130,85636,65836,609

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About LFCR

Lifecore Biomedical, Inc. (NASDAQ: LFCR) is a stock listed on the Nasdaq Stock Market under the ticker symbol LFCR. It last traded at $6.40 (Nov 18, 2026, 4:00 PM ET), up 0.2% on the day. That gives Lifecore Biomedical a market capitalisation of $242.2M.

Over the past 52 weeks LFCR has traded between $3.63 and $8.98.

For the quarter ended Mar 31, 2026 it reported a net loss of $15.0M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$15.0M
Sep 30, 2025—-$10.0M
May 25, 2025—-$1.1M
Feb 23, 2025—-$14.8M

From Lifecore Biomedical’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…